À´Ô´£ºÃ¿ÈÕÓý¶ù°Ù¿Æ ×÷Õߣº¶ù¿ÆÁõ»ªÒ½Éú 2018-01-12 10:37:26
¡¡¡¡ÃÀ¹úÒ»ÏîΪÆÚ³¬¹ý15ÄêµÄÁ÷¸ÐÒßÃç²»Á¼·´Ó¦µ÷²éÑо¿£¬Ò»¹²¹Û²ìÁË7.47ÒÚÈ˴εÄÁ÷¸ÐÒßÃç×¢É䣬·¢ÏÖ4ÀýÒòΪÑÏÖØ¹ýÃô·´Ó¦¶ø³öÏÖËÀÍöµÄ²¡Àý£¬ËùÒÔ³öÏÖÖÂÃüµÄ³¬Ãô·´Ó¦ÊǼ«º±¼ûµÄ¡£¡¾Vellozzi C, Burwen DR, et al. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009;27(15):2114. ¡¿¡£³öÏÖÃ÷È·µÄÁ÷¸ÐÒßÃçµÄËÙ·¢Ðͳ¬Ãô·´Ó¦Ö¢×´·¢ÉúÂʲ»µ½°ÙÍò·ÖÖ®¶þ¡£¶øÇÒÕâЩ³¬Ãô·´Ó¦Ò²ÎÞ·¨È·¶¨ÊǼ¦µ°¹ýÃôËùÖ¡£¡¾Tavares F, Delaigle A, et al. Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective.Vaccine. 2011;29(37):6402.¡¿
¡¡¡¡ËùÒÔ£¬×î½üACAAI£¨ÃÀ¹ú¹ýÃô·´Ó¦£¬Ïø´ºÍÃâÒßѧѧԺ£©·¢±íÔÚ¡¶ ±ä̬·´Ó¦¡¢Ïø´ºÍÃâÒßѧ¼ÍÊ¡·ÎÄÕ±íʾ£¬¹ýÈ¥¼¸Äê´óÁ¿µÄÑо¿±íÃ÷£¬¼¦µ°¹ýÃôµÄ¶ùͯ°üÀ¨ÄÇЩ³Ô¼¦µ°ÓÐÑÏÖØÎ£¼°ÉúÃüµÄ¹ýÃô·´Ó¦µÄ¶ùͯ£¬×¢ÉäÒ»¼ÁÁ÷¸ÐÒßÃ粢ûÓÐÃ÷ÏԵķ´Ó¦£¬ËùÒÔACAAI¸üÐÂÁ˼¦µ°¹ýÃôµÄÈËȺ½ÓÊÜÁ÷¸ÐÒßÃçµÄ°²È«ÐÔ¼°Á÷¸ÐÒßÃçÖ¸ÄÏ¡£Í¬Ê±Ä¿Ç°CDCÒßÃçÃâÒß×ÉѯίԱ»áÒ²¸üÐÂÁ˹ØÓÚ¼¦µ°¹ýÃôÈËȺµÄÁ÷¸ÐÒßÃçµÄÖ¸ÄÏ¡£
¡¡¡¡Ïà¹ØÍÆ¼ö£º
СÉý³õÊÔÌâ¡¢ÆÚÖÐÆÚÄ©Ì⡢Сѧ°ÂÊýÌâ
¾¡ÔÚ°ÂÊýÍø¹«ÖÚºÅ
¡¡¡¡ »¶ÓʹÓÃÊÖ»ú¡¢Æ½°åµÈÒÆ¶¯É豸·ÃÎÊÓ×½ÌÍø£¬Ó×¶ù½ÌÓýÎÒÃÇһ·Åã°éͬÐУ¡>>µã»÷²é¿´